MENU
+Compare
REGN
Stock ticker: NASDAQ
AS OF
Aug 12, 04:59 PM (EDT)
Price
$556.62
Change
+$10.68 (+1.96%)
Capitalization
57.86B

REGN Regeneron Pharmaceuticals Forecast, Technical & Fundamental Analysis

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for REGN with price predictions
Aug 11, 2025

REGN in upward trend: price rose above 50-day moving average on July 21, 2025

REGN moved above its 50-day moving average on July 21, 2025 date and that indicates a change from a downward trend to an upward trend. In of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where REGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for REGN crossed bullishly above the 50-day moving average on July 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REGN advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 239 cases where REGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for REGN moved out of overbought territory on July 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on REGN as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for REGN turned negative on August 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.933) is normal, around the industry mean (18.461). P/E Ratio (13.759) is within average values for comparable stocks, (53.401). Projected Growth (PEG Ratio) (1.118) is also within normal values, averaging (2.822). Dividend Yield (0.003) settles around the average of (0.049) among similar stocks. P/S Ratio (4.318) is also within normal values, averaging (286.886).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. REGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

REGN is expected to report earnings to fall 25.14% to $9.65 per share on October 30

Regeneron Pharmaceuticals REGN Stock Earnings Reports
Q3'25
Est.
$9.65
Q2'25
Beat
by $4.39
Q1'25
Missed
by $0.26
Q4'24
Beat
by $0.80
Q3'24
Beat
by $0.74
The last earnings report on August 01 showed earnings per share of $12.89, beating the estimate of $8.50. With 168.13K shares outstanding, the current market capitalization sits at 57.86B.
A.I.Advisor
published Dividends

REGN is expected to pay dividends on September 03, 2025

Regeneron Pharmaceuticals REGN Stock Dividends
A dividend of $0.88 per share will be paid with a record date of September 03, 2025, and an ex-dividend date of August 18, 2025. The last dividend of $0.88 was paid on June 06. Read more...
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FBTC103.882.28
+2.24%
Fidelity Wise Origin Bitcoin Fund
HTEC28.730.01
+0.02%
Robo Global® Hlthcare Tech & Innovt ETF
MYCK24.90-0.04
-0.17%
SPDR SSGA My2031 Corporate Bond ETF
EZM62.37-0.15
-0.25%
WisdomTree U.S. MidCap Earnings ETF
CVIE65.48-0.24
-0.37%
Calvert International Responsible ETF

REGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with ROIV. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-3.03%
ROIV - REGN
42%
Loosely correlated
-2.79%
IDYA - REGN
40%
Loosely correlated
-1.13%
SMMT - REGN
39%
Loosely correlated
-1.43%
INCY - REGN
39%
Loosely correlated
+1.02%
TECH - REGN
38%
Loosely correlated
-0.54%
More